Skip to main content

Peer Review reports

From: Study protocol of the GRoningen early-PD Ambroxol treatment (GREAT) trial: a randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA mutation

Original Submission
6 Feb 2024 Submitted Original manuscript
3 Mar 2024 Reviewed Reviewer Report
4 Mar 2024 Reviewed Reviewer Report
28 Mar 2024 Author responded Author comments - Olav Siemeling
Resubmission - Version 2
28 Mar 2024 Submitted Manuscript version 2
4 Apr 2024 Reviewed Reviewer Report
6 Apr 2024 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
8 Apr 2024 Editorially accepted
1 May 2024 Article published 10.1186/s12883-024-03629-9

You can find further information about peer review here.

Back to article page